AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
77.03
+0.13 (0.16%)
May 20, 2024, 12:35 PM EDT - Market open
AstraZeneca Revenue
AstraZeneca had revenue of $47.61B in the twelve months ending March 31, 2024, with 8.60% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.68B with 16.55% year-over-year growth. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.
Revenue (ttm)
$47.61B
Revenue Growth
+8.60%
P/S Ratio
5.01
Revenue / Employee
$529,600
Employees
89,900
Market Cap
238.91B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | 24.38B | 2.29B | 10.38% |
Dec 31, 2018 | 22.09B | -375.00M | -1.67% |
Dec 31, 2017 | 22.47B | -537.00M | -2.33% |
Dec 31, 2016 | 23.00B | -1.71B | -6.90% |
Dec 31, 2015 | 24.71B | -1.84B | -6.93% |
Dec 31, 2014 | 26.55B | 741.00M | 2.87% |
Dec 31, 2013 | 25.81B | -2.17B | -7.75% |
Dec 31, 2012 | 27.97B | -5.62B | -16.72% |
Dec 31, 2011 | 33.59B | 322.00M | 0.97% |
Dec 31, 2010 | 33.27B | 465.00M | 1.42% |
Dec 31, 2009 | 32.80B | 1.20B | 3.81% |
Dec 31, 2008 | 31.60B | 2.04B | 6.91% |
Dec 31, 2007 | 29.56B | 3.08B | 11.65% |
Dec 31, 2006 | 26.48B | 2.53B | 10.54% |
Dec 31, 2005 | 23.95B | 2.52B | 11.78% |
Dec 31, 2004 | 21.43B | 2.58B | 13.67% |
Dec 31, 2003 | 18.85B | 1.01B | 5.65% |
Dec 31, 2002 | 17.84B | - | - |
Dec 31, 2001 | - | - | - |
Dec 31, 2000 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
Novo Nordisk | 35.35B |
AZN News
- 10 hours ago - AstraZeneca plans to build $1.5 bln manufacturing facility in Singapore - Reuters
- 19 hours ago - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease - Business Wire
- 2 days ago - Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial - Reuters
- 4 days ago - AstraZeneca's investigational COVID drug meets primary goals in late-stage study - Reuters
- 5 days ago - Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Elected as a New Board Member - Accesswire
- 8 days ago - Pfizer and AstraZeneca announce new investments of nearly $1 billion in France - Reuters
- 11 days ago - AstraZeneca starts worldwide withdrawal of COVID vaccine - Skynews
- 11 days ago - AstraZeneca pulls its COVID-19 vaccine from the European market - Market Watch